Contact us to find out if we have the data you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple language support. Please visit our Contact page to see which office is open right now!

“China Healthcare Sector Analysis” is an exhaustive research by RNCOS on the expanding healthcare market of China. The report provides a detailed account of the more…

Dainippon Sumitomo Pharma (DSP) is a research-based pharmaceutical company, headquartered in Osaka, which has resulted from the merger of Dainippon Pharmaceutical (which acts more…

Highlights: This report: Describes product segments including drug testing devices by sample specimen, which includes blood, hair, oral fluid, sweat, and urine Offers more…

Kyowa currently ranks 42nd of all researched-based companies in terms of pharmaceutical sales. This report provides a full review of the company's activities together with more…

The District Sales Manager is the acknowledged cornerstone of pharmaceutical sales force effectiveness and high performance. Although the traditional DM role is well more…

China is the world's most populous country and fastest growing major economy. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical more…

The Israeli pharmaceutical market grew strongly in the 1990s, averaging around 10% per annum. This report is ideal for executives wanting to understand the key drivers in the more…

Around 90% of Romania's pharmaceutical market is supplied by imports. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market more…

Abstract This Health Industry Insights report assesses recent adoption rates of cell phone technologies in various U.S. demographic segments, the development of cell phone more…

Introduction The United States stands in stark contrast to Europe and Japan in terms of the freedom that manufacturers have to set-and increase-the prices of branded drugs in more…

Introduction Panic disorder (PD) affects a large number of people and has a large diagnosed and drug-treated population. Nonetheless, the pipeline for agents to treat PD more…

Introduction Drugs for disorders of the central nervous system (CNS) form the second-ranked therapeutic area in terms of global pharmaceutical sales, reaching total retail more…

Abstract With high penetration and usage frequency difficult to increase, the market for first aid products has experienced slow growth in recent years, a trend that is likely more…

The Baxter Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report more…

Report description The Bayer Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

The Biogen Idec Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report more…

The Boehringer Ingelheim Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This more…

Report description The Bristol-Myers Squibb Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading more…

Report description The CSL Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Introduction Billion-dollar deals. Hostile takeovers. Reverse mergers. Bidding wars. All of these are signs that Big Pharma is hungry for deals and is aggressively seeking, more…

Report description The Eisai Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

The Eli Lilly Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report more…

Report description The Forest Labs Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

The Genentech Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report more…

Teva's recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete understanding of the more…

This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, more…

Abstract Overview Introduction Datamonitor expects the antihypertensives market to reach $37 billion, across the seven major markets, by 2017. The growth will be drive more…

Report description The Abbott Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Report description The Alcon Labs Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Report description The Allergan Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Report description The Amgen Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Report description The AstraZeneca Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Report description The Biogen Idec Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created Cutting Edge Information's new report, "Oncology Market Forecast to 2013," explores the fiercely more…

This report: Makes a thorough evaluation of the animal therapeutic and diagnostic markets, including vaccines, pharmaceuticals, feed additives and diagnostics Covers worldwid more…

Report description The Astellas Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Report description The Daiichi Sankyo Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

This report: Describes various medical applications for nanomaterials including diagnostics, pharmaceuticals, medical devices and medical imaging Determines the current marke more…

The Menarini Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report more…

Report description The Mundipharma Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Overview Introduction In 2008, the six tumor types covered in this report are forecast to account for over 666,000 new cases of cancer, obviously representing an enormous mark more…

Report description The Ratiopharm Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma more…

Report description The Servier Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Report description The Stada Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Report description The Barr Pharmaceuticals Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading more…

Report description The Chugai Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

The rising prevalence of obesity is a growing problem in developed countries, with 32% of Americans and 17% of EU residents considered obese in 2008. The condition is more…

This report will provide industry planners, commercial developers and the investment community with a thorough review of the operating landscape for generic injectables. The more…

Introduction Novel noninvasive liver diagnostics are poised to revolutionize the diagnosis of liver disease and increase drug-treatment rates in this indication. In this more…

This is the latest most up-to-date Cancer Personalized Medicine Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Cancer more…

This report is about the molecular diagnostics market, including systems, consumables and clinical lab services. These key medical products and services use technologies that more…

SYNOPSIS This executive update provides an update on the reimbursement policy trends from the Center for Medicare and Medicaid (CMS) regarding digital health applications and more…

Report description The Partnering with Bigpharma: The Definitive Guide to Bigpharma Partnering Interests, Contacts and Agreements report provides the most comprehensive and more…

The global clinical trials business is worth an estimated $50bn in 2008, with a growth of rate of 10%. The market will show considerable growth in the future, as this more…

Often overshadowed by commercial interest in China and India, the countries of SE Asia offer both a growing market for biopharmaceuticals and a research-driven environment for more…

Report description The Actavis Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. more…

Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in Malaysia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in Thailand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail more…

Euromonitor International's Analgesics in the Philippines report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest more…

The current crisis in antibiotic R&D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, more…

Overview Introduction This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global more…

Aggressive adoption of cancer biomarkers will accelerate the growth of commercial markets for these products. This new report offers in-depth analysis of: The current can more…

China's demand for Diagnostic Reagents has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study more…

China's demand for Insulin has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines more…

Abstract The U.S. Complementary and Alternative Medicine (CAM) market has been growing steadily since 2003. Consisting of herbal and homeopathic remedies, purchases in the more…

Euromonitor International's Cough, Cold and Allergy Products in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It more…

Euromonitor International's Cough, Cold and Allergy Products in Chile report offers a comprehensive guide to the size and shape of the market at a national level. It provides more…

Euromonitor International's Cough, Cold and Allergy Products in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides more…

Euromonitor International's Cough, Cold and Allergy Products in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides more…

Euromonitor International's Cough, Cold and Allergy Products in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It more…